Cited by 400Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

The DOI matches its Crossref record; 102 of the 104 references it cites were found in a registry or an index.

Vancomycin-resistant enterococci: why are they here, and where do they come from?

Bonten, Marc JM, Willems, Rob, Weinstein, Robert A·2001·The Lancet Infectious Diseases

Open this paper in CoChat — free account

Abstract

Vancomcyin-resistant enterococci (VRE) have emerged as nosocomial pathogens in the past 10 years, causing epidemiological controversy. In the USA, colonisation with VRE is endemic in many hospitals and increasingly causes infection, but colonisation is absent in healthy people. In Europe, outbreaks still happen sporadically, usually with few serious infections, but colonisation seems to be endemic in healthy people and farm animals. Vancomycin use has been much higher in the USA, where emergence of ampicillin-resistant enterococci preceded emergence of VRE, making them very susceptible to the selective effects of antibiotics. In Europe, avoparcin, a vancomycin-like glycopeptide, has been widely used in the agricultural industry, explaining the community reservoir in European animals. Avoparcin has not been used in the USA, which is consistent with the absence of colonisation in healthy people. From the European animal reservoir, VRE and resistance genes have spread to healthy human beings and hospitalised patients. However, certain genogroups of enterococci in both continents seem to be more capable of causing hospital outbreaks, perhaps because of the presence of a specific virulence factor, the variant esp gene. By contrast with the evidence of a direct link between European animal and human reservoirs, the origin of American resistance genes remains to be established. Considering the spread of antibiotic-resistant bacteria and resistance genes, the emergence of VRE has emphasised the non-existence of boundaries between hospitals, between people and animals, between countries, and probably between continents.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(01)00145-1

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,310
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,237
Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90528-v · Cited by 935
Recommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.1086/647066 · Cited by 902
National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, Issued June 1999
(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 899
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 894
Effect of Antibiotic Therapy on the Density of Vancomycin-Resistant Enterococci in the Stool of Colonized Patients
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J., Hujer, A. M., Hutton‐Thomas, R., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 691
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
Aarestrup, F. M., Seyfarth, A. M., Emborg, H., Pedersen, K., Hendriksen, R. S., & Bager, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2054-2059.2001 · Cited by 653
Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 600
Emergence of Enterococcus as a Significant Pathogen
Moellering, R. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1173 · Cited by 583
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Vancomycin-Resistant Enterococcus faecium Bacteremia: Risk Factors for Infection
Edmond, M. B., Ober, J. F., WEINBAUM, D. L., Pfaller, M. A., Hwang, T., Sanford, M. D., & Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1126 · Cited by 488
Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center
Morris, J. G., Shay, D. K., Hebden, J. N., McCarter, R. J., Perdue, B. E., Jarvis, W., Johnson, J. A., Dowling, T. C., Polish, L. B., & Schwalbe, R. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00002 · Cited by 475
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
Boyce, J. M., Opal, S. M., Chow, J. W., Zervos, M., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 474
Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers
Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P. L., Pitsakis, P. G., Woods, G. L., Kaye, D., Levison, M. E., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-112 · Cited by 460
The Role of "Colonization Pressure" in the Spread of Vancomycin-Resistant Enterococci
Bonten, M. J. M., Slaughter, S., Ambergen, A. W., Hayden, M. K., van Voorhis, J., Nathan, C., & Weinstein, R. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1127 · Cited by 440
Self-citation
Infection-Derived Enterococcus faecalis Strains Are Enriched in esp , a Gene Encoding a Novel Surface Protein
Shankar, V., Baghdayan, A. S., Huycke, M. M., Lindahl, G., & Gilmore, M. S. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.193-200.1999 · Cited by 430
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci
Bonten, M. J. M., Hayden, M. K., Nathan, C., van Voorhis, J., Matushek, M. G., Slaughter, S., Rice, T. W., & Weinstein, R. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02331-8 · Cited by 414
Self-citation
Glycopeptide resistance in enterococci
Arthur, M., REYNOLDS, P., & Courvalin, P. M. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 412
Nosocomial Outbreak Due to Enterococcus faecium Highly Resistant to Vancomycin, Penicillin, and Gentamicin
Handwerger, S., Raucher, B. G., Altarac, D., Monka, J., Marchione, S., Singh, K. V., Murray, B. E., Wolff, J., & Walters, B. A. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.750 · Cited by 409
Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs
Austin, D. J., Bonten, M. J. M., Weinstein, R. A., Slaughter, S., & Anderson, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6908 · Cited by 389
Self-citation
Role of Enterococcus faecalis Surface Protein Esp in the Pathogenesis of Ascending Urinary Tract Infection
Shankar, N., Lockatell, C. V., Baghdayan, A. S., Drachenberg, C., Gilmore, M. S., & Johnson, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4366-4372.2001 · Cited by 338
Emergence of vancomycin-resistant enterococci in New York City
Frieden, T. R., Munsiff, S. S., Williams, G., Faur, Y. C., Kreiswirth, B. N., Low, D. E., Willey, B. M., Warren, S., & Eisner, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)91285-t · Cited by 337
The antibiotic paradox: how miracle drugs are destroying the miracle
(1993) · Choice Reviews Online · doi:10.5860/choice.30-4438 · Cited by 329
Variant esp gene as a marker of a distinct genetic lineage of vancomycinresistant Enterococcus faecium spreading in hospitals
Willems, R. J. L., Homan, W. L., Top, J., van Santen-Verheuvel, M., Tribe, D. E., Manzioros, X., Gaillard, S., Vandenbroucke‐Grauls, C. M. J. E., Mascini, E. M., van Kregten, E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04205-7 · Cited by 323
Self-citation
Control of Vancomycin-Resistant Enterococcus in Health Care Facilities in a Region
Ostrowsky, B. E., Trick, W. E., Sohn, A. H., Quirk, S. B., Holt, S. C., Carson, L. A., Hill, B. C., Arduino, M. J., Kuehnert, M. J., & Jarvis, W. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441903 · Cited by 306
Decreased Incidence of VanA-type Vancomycin-Resistant Enterococci Isolated from Poultry Meat and from Fecal Samples of Humans in the Community after Discontinuation of Avoparcin Usage in Animal Husbandry
Klare, I., Badstübner, D., Konstabel, C., BÖHME, G., Claus, H., & Witte, W. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.45 · Cited by 304
A Comparison of the Effect of Universal Use of Gloves and Gowns with That of Glove Use Alone on Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit
Slaughter, S., Hayden, M. K., Nathan, C., Hu, T.-C., Rice, T., Voorhis, J. V., Matushek, M., Franklin, C., & Weinstein, R. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-6-199609150-00004 · Cited by 302
Self-citation
“Colonization Pressure” and Risk of Acquisition of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit
Merrer, J., Santoli, F., Vecchi, C. A. D., Tran, B., Jonghe, B. D., & Outin, H. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501721 · Cited by 285
Recommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140952 · Cited by 283
The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units
Fridkin, S. K., Edwards, J. R., Courval, J. M., Hill, H., Tenover, F. C., Lawton, R. M., Gaynes, R. P., & McGowan, J. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-3-200108070-00009 · Cited by 280
Historical Yearly Usage of Vancomycin
Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1303 · Cited by 277
Emergence of Vancomycin-Resistant Enterococci
Rice, L. B. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010205 · Cited by 275
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 274
Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant Enterococci
van der Auwera, P., Pensart, N., Korten, V., Murray, B. E., & Leclercq, R. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1129 · Cited by 232
National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-April 2000, Issued June 2000
(2000) · American Journal of Infection Control · doi:10.1067/mic.2000.110544 · Cited by 221
Molecular Diversity and Evolutionary Relationships of Tn 1546 -Like Elements in Enterococci from Humans and Animals
Willems, R. J. L., Top, J., van den Braak, N., van Belkum, A., Mevius, D. J., Hendriks, G., van Santen-Verheuvel, M., & van Embden, J. D. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.483 · Cited by 215
Self-citation
Genetic Characterization of vanG , a Novel Vancomycin Resistance Locus of Enterococcus faecalis
McKessar, S. J., Berry, A. M., Bell, J. M., Turnidge, J. D., & Paton, J. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3224-3228.2000 · Cited by 210
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 208
Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium
Jordens, J. Z., Bates, J. L., & Griffiths, D. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.4.515 · Cited by 198
Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution
Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., Girolami, P. C. D., Ferraro, M. J., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2180 · Cited by 196
Infection-Control Measures Reduce Transmission of Vancomycin-Resistant Enterococci in an Endemic Setting
Montecalvo, M. A., Jarvis, W. R., Uman, J. E., Shay, D. K., Petrullo, C., Rodney, K., Gedris, C. A., Horowitz, H. W., & Wormser, G. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00006 · Cited by 194
Host Specificity of Vancomycin‐ResistantEnterococcus faecium
Willems, R. J. L., Top, J., van den Braak, N., van Belkum, A., Endtz, H. P., Mevius, D. J., Stobberingh, E. E., van den Bogaard, A. E. J. M., & van Embden, J. D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315752 · Cited by 182
Self-citation
A 25-year study of nosocomial bacteremia in an adult intensive care unit
Edgeworth, J. D., Treacher, D., & Eykyn, S. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00002 · Cited by 178
Molecular Characterization of Vancomycin-Resistant Enterococci from Hospitalized Patients and Poultry Products in The Netherlands
van den Braak, N., van Belkum, A., van Keulen, M., Vliegenthart, J. S., Verbrugh, H. A., & Endtz, H. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1927-1932.1998 · Cited by 178
Diversity of VanA Glycopeptide Resistance Elements in Enterococci from Humans and Nonhuman Sources
Woodford, N., Adebiyi, A.-M. A., Palepou, M.-F. I., & Cookson, B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.502 · Cited by 177
Prevalence of Vancomycin-Resistant Enterococci in Europe
Schouten, M. A., Hoogkamp-Korstanje, J. A. A., Meis, J. F. G. M., & Voss, A. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000390 · Cited by 175
Enterococci with Glycopeptide Resistance in Turkeys, Turkey Farmers, Turkey Slaughterers, and (Sub)Urban Residents in the South of The Netherlands: Evidence for Transmission of Vancomycin Resistance from Animals to Humans?
Stobberingh, E. E., van den Bogaard, A. E. J. M., London, N. H. H. J., Driessen, C., Top, J., & Willems, R. J. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2215 · Cited by 170
Self-citation
Enterococci as emerging pathogens of humans
Morrison, D., Woodford, N., & Cookson, B. (1997) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.83.s1.10.x · Cited by 170
Molecular Analysis of Tn 1546 in Enterococcus faecium Isolated from Animals and Humans
Jensen, L. B., Ahrens, P., Dons, L. E., Jones, R. N., Hammerum, A. M., & Aarestrup, F. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.437-442.1998 · Cited by 167
In Vivo Development of Teicoplanin Resistance in a VanB Enterococcus faecium Isolate
Hayden, M. K., Trenholme, G. M., Schultz, J. E., & Sahm, D. F. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1224 · Cited by 164
The effect of banning avoparcin on VRE carriage in The Netherlands
van den Bogaard, A. E. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.146 · Cited by 163
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands
Endtz, H. P., van den Braak, N., van Belkum, A., Kluytmans, J. A. J. W., Koeleman, J. G. M., Spanjaard, L., Voss, A., Weersink, A. J. L., Vandenbroucke‐Grauls, C. M. J. E., Buiting, A. G. M., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3026-3031.1997 · Cited by 159
Insights into the Epidemiology and Control of Infection with Vancomycin‐Resistant Enterococci
Hayden, M. K. (2000) · Clinical Infectious Diseases · doi:10.1086/318126 · Cited by 158
d -Ala- d -Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB
Marshall, C. G., Broadhead, G., Leskiw, B. K., & Wright, G. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6480 · Cited by 146
The Association Between Antecedent Vancomycin Treatment and Hospital-Acquired Vancomycin-Resistant Enterococci
Carmeli, Y., Samore, M. H., & Huskins, W. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.20.2461 · Cited by 145
Effect of Parenteral Antibiotic Administration on Persistence of Vancomycin‐ResistantEnterococcus faeciumin the Mouse Gastrointestinal Tract
Donskey, C. J., Hanrahan, J., Hutton, R. A., & Rice, L. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/314874 · Cited by 139
Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium
Handwerger, S., & Skoble, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2446 · Cited by 133
Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium During Its Emergence in a City in Southern Texas
Moreno, F., Grota, P. G., Crisp, C., Magnon, K. C., MELCHER, G. P., Jorgensen, J. H., & PATTERSON, J. E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1234 · Cited by 128
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces
Stinear, T. P., Olden, D., Johnson, P. D. R., Davies, J. K., & Grayson, M. L. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04206-9 · Cited by 127
Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States
Handwerger, S., Skoble, J., Discotto, L. F., & Pucci, M. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.362 · Cited by 126
Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned
Borgen, K., Simonsen, G. S., Sundsfjord, A., Wasteson, Y., Olsvik, Ø., & Kruse, H. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01137.x · Cited by 124
High prevalence of colonization with vancomycin- and pristinamycin- resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame?
van den Bogaard, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.454 · Cited by 123
Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin
Welton, L., Thal, L. A., Perri, M. B., Donabedian, S. M., McMahon, J., Chow, J. W., & Zervos, M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.705 · Cited by 107
Skin Colonization with Vancomycin-Resistant Enterococci Among Hospitalized Patients with Bacteremia
Beezhold, D. W., Slaughter, S., Hayden, M. K., Matushek, M. G., Nathan, C., Trenholme, G. M., & Weinstein, R. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.704 · Cited by 96
Self-citation
The Changing Molecular Epidemiology and Establishment of Endemicity of Vancomycin Resistance in Enterococci at One Hospital over a 6‐Year Period
Kim, W. J., Weinstein, R. A., & Hayden, M. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314564 · Cited by 90
Self-citation
Vancomycin-resistant enterococci
Uttley, A. H. C., Woodford, N., Johnson, A. P., Cookson, B., George, R. C., Wilcox, M., Spencer, R. C., Weeks, G., Frieden, T. R., Munsiff, S. S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91440-w · Cited by 85
vanA and vanB Incorporate into an Endemic Ampicillin-Resistant Vancomycin-Sensitive Enterococcus faecium Strain: Effect on Interpretation of Clonality
Suppola, J., Kolho, E., Salmenlinna, S., Tarkka, E., Vuopio‐Varkila, J., & Vaara, M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.3934-3939.1999 · Cited by 83
Quinupristin/Dalfopristin-Resistant Enterococci of the satA ( vatD ) and satG ( vatE ) Genotypes from Different Ecological Origins in Germany
Werner, G., Klare, I., Heier, H., Hinz, K.-H., BÖHME, G., Wendt, M., & Witte, W. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.37 · Cited by 81
Comparison of Glycopeptide-Resistant Enterococcus faecium Isolates and Glycopeptide Resistance Genes of Human and Animal Origins
Descheemaeker, P. R. M., Chapelle, S., Devriese, L. A., Butaye, P., Vandamme, P. A. R., & Goossens, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2032 · Cited by 81
Vancomycin-resistant enterococci in cats and dogs
van Belkum, A., van den Braak, N., Thomassen, R., Verbrugh, H. A., & Endtz, H. P. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64973-2 · Cited by 80
Differences in the Occurrence of Two Base Pair Variants of Tn 1546 from Vancomycin-Resistant Enterococci from Humans, Pigs, and Poultry
Jensen, L. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2463 · Cited by 77
Effect of Parenteral Antibiotic Administration on the Establishment of Colonization with Vancomycin‐ResistantEnterococcus faeciumin the Mouse Gastrointestinal Tract
Donskey, C. J., Hanrahan, J., Hutton, R. A., & Rice, L. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315428 · Cited by 76
Patients in Long-Term Care Facilities: A Reservoir for Vancomycin-Resistant Enterococci
Elizaga, M. L., Weinstein, R. A., & Hayden, M. K. (2002) · Clinical Infectious Diseases · doi:10.1086/338461 · Cited by 72
Self-citation
Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci
Palepou, M.-F. I. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.605 · Cited by 70
Frequency of esp in Enterococcus faecium isolates
Woodford, N., Soltani, M., & Hardy, K. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05726-9 · Cited by 67
Outbreak of Vancomycin-Resistant Enterococci in a Hospital in Gdansk, Poland, due to Horizontal Transfer of Different Tn1546-Like Transposon Variants and Clonal Spread of Several Strains
Kawalec, M., Gniadkowski, M., & Hryniewicz, W. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3317-3322.2000 · Cited by 66
VRE and meat
Schouten, Voss, A., & Hoogkamp-Korstanje, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62461-0 · Cited by 61
Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms
Patel, R. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09032.x · Cited by 53
Historical Yearly Usage of Glycopeptides for Animals and Humans: The American-European Paradox Revisited
Wegener, H. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3049 · Cited by 48
Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium
Baldassarri, L., Bertuccini, L., Ammendolia, M. G., Gherardi, G., & Creti, R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04919-9 · Cited by 46
Typeability of Tn 1546 -like Elements in Vancomycin-Resistant Enterococci Using Long-Range PCRs and Specific Analysis of Polymorphic Regions
Simonsen, G. S., Myhre, M. R., Hegstad, K., Olsvik, Ø., & Sundsfjord, A. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.49 · Cited by 44
Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain
MacKinnon, M., Drebot, M., & Tyrrell, G. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1805 · Cited by 42
Molecular Analysis of Tn 1546 -Like Elements in Vancomycin-Resistant Enterococci Isolated from Patients in Europe Shows Geographic Transposon Type Clustering
Schouten, M. A., Willems, R. J. L., Kraak, W. A. G., Top, J., Hoogkamp-Korstanje, J. A. A., & Voß, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.986-989.2001 · Cited by 42
Self-citation
Methaemoglobin during nitric oxide therapy with high-frequency ventilation
Kinsella, J. P., & Abman, S. H. (1993) · The Lancet · doi:10.1016/0140-6736(93)91439-s · Cited by 40
Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children
Nourse, C. B., Byrne, C., MURPHY, H., Kaufmann, M. E., Clarke, A., & BUTLER, K. M. (2000) · Epidemiology and Infection · doi:10.1017/s095026889900326x · Cited by 39
Role of Transposon Tn 5482 in the Epidemiology of Vancomycin-Resistant Enterococcus faecium in the Pediatric Oncology Unit of a New York City Hospital
de LENCASTRE, H., Brown, A. E., Chung, M., Armstrong, D., & Tomasz, A. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.113 · Cited by 39
Intrahospital Spread of Vancomycin-resistant Enterococcus faecium in Sweden
Torell, E., Fredlund, H., Törnquist, E., Myhre, E. B., Sjöberg, L., & Sundsfjord, A. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709019039 · Cited by 39
Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit
Brown, A. R., Amyes, S. G. B., Paton, R., Plant, W. D., Stevenson, G. M., Winney, R. J., & Miles, R. S. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90090-1 · Cited by 36
Genotypic Characterization of a Nosocomial Outbreak of VanA Enterococcus faecalis
Biavasco, F., Miele, A., Vignaroli, C., Manso, E., Lupidi, R., & Varaldo, P. E. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.231 · Cited by 33
Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates
Bodnar, U. R., Noskin, G. A., Suriano, T., Cooper, I., Reisberg, B. E., & Peterson, L. R. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.9.2129-2132.1996 · Cited by 31
Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999
Johnson, A. P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.125 · Cited by 27
EnterobacterSpecies in a Pediatric Hospital: Horizontal Transfer or Selection in Individual Patients?
de Man, P., van der Veeke, E., Leemreijze, M., van Leeuwen, W., Vos, M. D., van den Anker, J. N., Verbrugh, H. A., & van Belkum, A. (2001) · The Journal of Infectious Diseases · doi:10.1086/322014 · Cited by 27
Vancomycin-resistant-enterococci - Colonization of 24 patients on a pediatric oncology unit
Schuster, F. R., Graubner, U. B., Schmid, I., Weiss, M., & Belohradsky, B. H. (1998) · Klinische Pädiatrie · doi:10.1055/s-2008-1043889 · Cited by 26
Vancomycin-resistant enterococci in vegetarians
van den Braak, N., Kreft, D., van Belkum, A., Verbrugh, H. A., & Endtz, H. P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61856-9 · Cited by 25
Diversity of Tn 1546 Elements in Clinical Isolates of Glycopeptide-Resistant Enterococci from Scottish Hospitals
Brown, A. R., Townsley, A. C., & Amyes, S. G. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1309-1311.2001 · Cited by 21
Reality Check: Should We Try to Detect and Isolate Vancomycin-Resistant Enterococci Patients?
Ostrowsky, B. E., Steinberg, J., Farr, B. M., Sohn, A. H., Sinkowitz‐Cochran, R. L., & Jarvis, W. R. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501874 · Cited by 20
Internal size variations in Tn1546-like elements due to the presence of IS1216V
Jensen, L. B. ̄. ⁄. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13339.x · Cited by 19
Characterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece
Demertzi, E., PALEPOU, M.-F. I., Kaufmann, M. E., Avlamis, A., & Woodford, N. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-8-682 · Cited by 14
[Vancomycin-resistant Enterococcus faecium outbreak in a nephrology ward].
van der Steen, L. F., Bonten, M. J. M., van Kregten, E., Harssema-Poot, J. J., Willems, R. J. L., & Gaillard, S. (2000) · PubMed · Cited by 13
Self-citation
[Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital].
Mascini, E. M., Gigengack-Baars, A. C. M., Hené, R. J., Hopmans, T. E. M., Weersink, A. J. L., & Bonten, M. J. M. (2000) · PubMed · Cited by 5
Self-citation

Research works printed but not linked: 5

Hayden MK, Blom DW, Lyle EA, et al. The risk of hand and glove contamination by health care workers after contact with a VRE-positive patient or the patients' environment. Proceedings of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago; Dec 2001: abstract K/1334
Vandenbroucke-Grauls, 2000, Succesvolle bestrijding van een epidemie met vancomycineresistente Enterococcus faecium op een hematologische afdeling, Ned Tijdschr Med Microbiol, 8, S28
van der Steen, 2000, Uitbraak van vancomycine-resistente Enterococcus faecium op een afdeling nefrologie, Ned Tijdschr Geneesk, 144, 2568
Mascini, 2000, Epidemische verheffing van verscheidene genotypen van vancomycine-resistente Enterococcus faecium in een Academisch Ziekenhuis, Ned Tijdschr Geneesk, 144, 2572
Routsi, 2001, Clinical and molecular surveillance of glycopeptide-resistant Enterococcus faecium in a Greek ICU, Intens Care Med, 27, S151

Sorted by citations

Antibiotic Resistance Genes as Emerging Contaminants: Studies in Northern Colorado
Pruden, A. J., Pei, R., Storteboom, H. N., & Carlson, K. H. (2006) · Environmental Science & Technology · doi:10.1021/es060413l · Cited by 1,943
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
Boyce, J. M., Potter-Bynoe, G., Chenevert, C., & King, T. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/502213 · Cited by 1,758
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O’Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,571
Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
Fishman, N. O., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/665010 · Cited by 683
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 682

See all 400

Authors: Bonten, M. J., Willems, R., & Weinstein, R. A.
Affiliations: University Medical Center Utrecht (NL)
National Institute for Public Health and the Environment (NL)
John H. Stroger, Jr. Hospital of Cook County (US)
Corresponding author: Bonten, Marc JM
ORCID: Bonten, Marc JM
Willems, Rob
Weinstein, Robert A
Venue: The Lancet Infectious Diseases
Publisher: Elsevier BV
Published: 2001-12
Volume: 1
Issue: 5
Pages: 314-325
ISSN: 1473-3099 (ISSN-L)
DOI: 10.1016/s1473-3099(01)00145-1
OpenAlex: W1998796942
Cited by: 400
References: 104
Citations by year: 2026: 4 · 2025: 4 · 2024: 10 · 2023: 17 · 2022: 6 · 2021: 10 · 2020: 17 · 2019: 12 · 2018: 14 · 2017: 18 · 2016: 17 · 2015: 11 · 2014: 18 · 2013: 28 · 2012: 25
FWCI: 1.20
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords: vancomycin-resistant enterococci, nosocomial infections, antibiotic resistance, avoparcin, reservoir hosts, human colonization, hospital outbreak, virulence genes, esp gene, resistance gene spread, antimicrobial use
MeSH terms: Animals, Animal Husbandry, Anti-Bacterial Agents, Bacterial Proteins, Cross Infection, Disease Outbreaks, Europe, Humans, Membrane Proteins, North America, Vancomycin, Gram-Positive Bacterial Infections, Enterococcus, Enterococcus faecium, Infection Control, Vancomycin Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vancomycin-resistant enterococci: why are they here, and where do they come from?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks